Los Angeles Capital Management LLC lessened its holdings in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 4.9% during the 3rd quarter, HoldingsChannel reports. The fund owned 3,290 shares of the technology company’s stock after selling 170 shares during the quarter. Los Angeles Capital Management LLC’s holdings in Plexus were worth $450,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. Quest Partners LLC increased its position in Plexus by 36,700.0% in the second quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock worth $38,000 after buying an additional 367 shares in the last quarter. Innealta Capital LLC purchased a new position in Plexus during the second quarter valued at approximately $51,000. Farther Finance Advisors LLC boosted its position in shares of Plexus by 89.4% in the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock worth $63,000 after purchasing an additional 219 shares during the period. EntryPoint Capital LLC increased its stake in shares of Plexus by 56.2% in the first quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock worth $93,000 after purchasing an additional 351 shares in the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Plexus by 190.1% during the 3rd quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock valued at $104,000 after purchasing an additional 498 shares during the period. 94.45% of the stock is currently owned by hedge funds and other institutional investors.
Plexus Price Performance
Shares of Plexus stock opened at $153.13 on Friday. The firm has a market cap of $4.17 billion, a PE ratio of 38.19 and a beta of 0.87. The stock has a 50 day moving average of $139.43 and a 200 day moving average of $122.29. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07. Plexus Corp. has a 12 month low of $90.18 and a 12 month high of $169.41.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on the company. Needham & Company LLC increased their price target on Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research note on Friday, October 25th. StockNews.com cut Plexus from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th. Benchmark boosted their price target on Plexus from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Monday, October 28th. Finally, KeyCorp assumed coverage on shares of Plexus in a report on Tuesday, October 22nd. They set a “sector weight” rating for the company. Four equities research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $133.50.
Check Out Our Latest Research Report on Plexus
Insider Transactions at Plexus
In related news, insider Michael J. Running sold 579 shares of Plexus stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $153.93, for a total value of $89,125.47. Following the completion of the transaction, the insider now owns 1,569 shares in the company, valued at approximately $241,516.17. This trade represents a 26.96 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Oliver K. Mihm sold 5,691 shares of the company’s stock in a transaction that occurred on Wednesday, November 6th. The shares were sold at an average price of $167.06, for a total value of $950,738.46. Following the sale, the chief operating officer now owns 19,585 shares in the company, valued at approximately $3,271,870.10. This trade represents a 22.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 35,552 shares of company stock worth $5,500,872 in the last three months. Insiders own 2.39% of the company’s stock.
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Stories
- Five stocks we like better than Plexus
- What Are Dividend Challengers?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- 10 Best Airline Stocks to Buy
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.